FDA Transparency Blog

The next public meeting on transparency will be held Tuesday, November 3, 2009. The task force plans to use a discussion group format to receive detailed and in-depth comments on three specific issues related to transparency at FDA. The topics to be covered are: (1) early communication about emerging safety issues concerning FDA-regulated products, (2) disclosure of information about product applications that are abandoned (i.e., no work is being done or will be undertaken to have the application approved) or withdrawn by the applicant before approval, and (3) communication of agency decisions about pending product applications.

For each topic, a panel will discuss a case study about the topic and answer questions that may be posed by task force members. Audience members will also have an opportunity to comment and ask questions following each discussion group.

The meeting will be held from 9 a.m. to 3 p.m. at the National Transportation Safety Board (NTSB) Conference Center in downtown DC. You can find information about participating in the meeting and/or submitting comments to the task force here. The task force is also looking into webcasting this meeting.